However, no correlation between XRCC2 expression and patient age, gender, lymph node metastasis, depth of invasion, or degree of differentiation was observed (P > 0.05; Table 1). The gene discussed is XRCC2; the disease is metastatic malignant neoplasm in the lymph nodes.